GoodRx Holdings, Inc. - Common Stock (GDRX)

Q1 2024 13F Holders as of 3/31/2024

Type / Class
Equity / Common Stock
Shares outstanding
98.7M
Number of holders
156
Total 13F shares, excl. options
129M
Shares change
-12.2M
Total reported value, excl. options
$914M
Value change
-$85.9M
Put/Call ratio
0.74
Number of buys
85
Number of sells
-58
Price
$7.10

Significant Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q1 2024

187 filings reported holding GDRX - GoodRx Holdings, Inc. - Common Stock as of Q1 2024.
GoodRx Holdings, Inc. - Common Stock (GDRX) has 156 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 129M shares .
Largest 10 shareholders include Francisco Partners Management, LP (70.1M shares), VANGUARD GROUP INC (8.1M shares), AMERIPRISE FINANCIAL INC (7.44M shares), Silver Lake Group, L.L.C. (3.53M shares), LAKEWOOD CAPITAL MANAGEMENT, LP (3.31M shares), RENAISSANCE TECHNOLOGIES LLC (3.08M shares), MILLENNIUM MANAGEMENT LLC (2.99M shares), Petrus Trust Company, LTA (2.3M shares), Rubric Capital Management LP (2.12M shares), and Rip Road Capital Partners LP (2.06M shares).
This table shows the top 156 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.